Advertisement
Review Article| Volume 30, ISSUE 2, P467-473, June 2010

Download started.

Ok

Recent Developments and Future Directions of Alloimmunization to Transfused Blood Products

Published:April 28, 2010DOI:https://doi.org/10.1016/j.cll.2010.02.012

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Heddle N.M.
        • Soutar R.L.
        • O'Hoski P.L.
        • et al.
        A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion.
        Br J Haematol. 1995; 91: 1000-1005
        • Hoeltge G.A.
        • Domen R.E.
        • Rybicki L.A.
        • et al.
        Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993.
        Arch Pathol Lab Med. 1995; 119: 42-45
        • Godeau B.
        • Fromont P.
        • Seror T.
        • et al.
        Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
        Br J Haematol. 1992; 81: 395-400
        • Kiefel V.
        • Konig C.
        • Kroll H.
        • et al.
        Platelet alloantibodies in transfused patients.
        Transfusion. 2001; 41: 766-770
        • Slichter S.J.
        Platelet refractoriness and alloimmunization.
        Leukemia. 1998; 12: S51-S53
        • Taaning E.
        • Simonsen A.C.
        • Hjelms E.
        • et al.
        Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
        Vox Sang. 1997; 72: 238-241
        • Heal J.M.
        • Cowles J.
        • Masel D.
        • et al.
        Antibodies to plasma proteins: an association with platelet transfusion refractoriness.
        Br J Haematol. 1992; 80: 83-90
        • Medzhitov R.
        Recognition of microorganisms and activation of the immune response.
        Nature. 2007; 449: 819-826
        • Takeda K.
        • Kaisho T.
        • Akira S.
        Toll-like receptors.
        Annu Rev Immunol. 2003; 21: 335-376
        • Hendrickson J.E.
        • Chadwick T.E.
        • Roback J.D.
        • et al.
        Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.
        Blood. 2007; 110: 2736-2743
        • Hendrickson J.E.
        • Desmarets M.
        • Deshpande S.S.
        • et al.
        Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.
        Transfusion. 2006; 46: 1526-1536
        • Yu J.
        • Heck S.
        • Yazdanbakhsh K.
        Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.
        Am J Hematol. 2007; 82: 691-696
        • Zimring J.C.
        • Hendrickson J.E.
        The role of inflammation in alloimmunization to antigens on transfused red blood cells.
        Curr Opin Hematol. 2008; 15: 631-635
        • Hendrickson J.E.
        • Roback J.D.
        • Hillyer C.D.
        • et al.
        Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells.
        Transfusion. 2008; 48: 1869-1877
        • Yazer M.H.
        • Triulzi D.J.
        • Shaz B.
        • et al.
        Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?.
        Transfusion. 2009; 49: 1070-1075
        • Tatari-Calderone Z.
        • Minniti C.P.
        • Kratovil T.
        • et al.
        rs660 polymorphism in Ro52 (SSA1;TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunizaiton in sickle cell disease.
        Mol Immunol. 2009; 47: 64-70
        • Hendrickson J.E.
        • Hod E.A.
        • Spitalnik S.L.
        • et al.
        Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen.
        Transfusion. 2009; 50: 642-648
        • Kaufman J.
        • Spinelli S.L.
        • Schultz E.
        • et al.
        Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion.
        J Thromb Haemost. 2007; 5: 788-796
        • Dierselhuis M.
        • Goulmy E.
        The relevance of minor histocompatability antigens in solid organ transplantation.
        Curr Opin Organ Transplant. 2009; 14: 419-425
        • Desmarets M.
        • Cadwell C.M.
        • Peterson K.R.
        • et al.
        Minor histocompatability antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model.
        Blood. 2009; 114: 2315-2322
        • Patel S.R.
        • Cadwell C.M.
        • Medford A.
        • et al.
        Transfusion of minor histocompatability antigen-mismatched platelets induces rejection of bone marrow transplants in mice.
        J Clin Invest. 2009; 119: 2787-2794
        • Lerut E.
        • Van Damme B.
        • Noizat-Pirenne F.
        • et al.
        Duffy and Kidd blood group antigens: minor histocompatability antigens involved in renal allograft rejection?.
        Transfusion. 2007; 47: 28-40
        • Deeg H.J.
        • Self S.
        • Storb R.
        • et al.
        Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors.
        Blood. 1986; 68: 1363-1368
        • Champlin R.E.
        • Horowitz M.M.
        • van Bekkum D.W.
        • et al.
        Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.
        Blood. 1989; 73: 606-613
        • Gluckman E.
        • Horowitz M.M.
        • Champlin R.E.
        • et al.
        Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
        Blood. 1992; 79: 269-275